{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-028851","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2023-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.741823+00:00","generated_at":"2026-06-17T03:57:59.125090+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Director Karin Eastham not standing for re-election at Nektar's 2023 annual meeting","bullets":["Karin Eastham informed Board she will not stand for re-election, completing term at 2023 annual meeting.","Departure is not due to any disagreement with the company on operations, policies, or practices.","Eastham served approximately five years as a director; no replacement announced.","Company thanks Eastham for her service."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-028851","json":"https://secwatch.observer/filing/0001213900-23-028851.json","markdown":"https://secwatch.observer/filing/0001213900-23-028851.md","text":"https://secwatch.observer/filing/0001213900-23-028851.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000121390023028851/0001213900-23-028851-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000121390023028851/ea176784-8k_nektartherap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T03:57:59.125090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a99049910","claim":"Karin Eastham departed as Director at NEKTAR THERAPEUTICS.","evidence_excerpt":"On April 6, 2023, Karin Eastham informed the Board of Directors (the “Board”) of Nektar Therapeutics (the “Company”) that she has elected not to stand for re-election and will complete her term on the Board at the conclusion of the Company’s 2023 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/906709/000121390023028851/0001213900-23-028851-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected not to stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}